NCT03742466

Brief Summary

Carpal tunnel syndrome is a common peripheral entrapment neuropathy, this study aims to investigate if, and to what extent local ozone therapy could offer symptom improvement in scleroderma patients with Carpal tunnel syndrome

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 10, 2018

Completed
Same day until next milestone

Study Start

First participant enrolled

November 10, 2018

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 15, 2018

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2019

Completed
Last Updated

August 5, 2020

Status Verified

August 1, 2020

Enrollment Period

9 months

First QC Date

November 10, 2018

Last Update Submit

August 4, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • to assess pain alleviation through the visual analog scale (VAS)

    visual analog scale of pain value of (0 cm) no pain , and value of (10 cm) worst pain

    6 months

Secondary Outcomes (1)

  • Changes in median nerve conduction parameters

    6 months

Study Arms (2)

Ozone

ACTIVE COMPARATOR

After prepping and draping the area, intracarpal injection of ozone/oxygen mixture (20 ml, 25μg/ml) will be performed under sonographic guidance

Drug: Ozone

methylprednisolone acetate

ACTIVE COMPARATOR

After prepping and draping the area, intracarpal injection of methylprednisolone acetate 40mg, and 40 mg lidocaine (20 ml, volume) will be performed under sonographic guidance

Drug: methylprednisolone acetate

Interventions

OzoneDRUG

After prepping and draping the area, intracarpal injection of ozone/oxygen mixture (20 ml, 25μg/ml) will be performed under sonographic guidance

Ozone

After prepping and draping the area, intracarpal injection of methylprednisolone acetate 40mg, and 40 mg lidocaine (20 ml, volume) will be performed under sonographic guidance

methylprednisolone acetate

Eligibility Criteria

Age20 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • adult patients with scleroderma
  • complaining of carpal tunnel syndrome of 3-month duration or more
  • diagnosed axonal neuropathy using electrodiagnosis, nerve conduction study

You may not qualify if:

  • patient refusal
  • infection at the site of intervention
  • previous injection in the recent 3 months
  • Coagulopathy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Emad Zarief Kamel Said

Asyut, 71111, Egypt

Location

MeSH Terms

Conditions

Carpal Tunnel SyndromeChronic PainScleroderma, Diffuse

Interventions

OzoneMethylprednisolone Acetate

Condition Hierarchy (Ancestors)

Median NeuropathyMononeuropathiesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesNerve Compression SyndromesCumulative Trauma DisordersSprains and StrainsWounds and InjuriesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsScleroderma, SystemicConnective Tissue DiseasesSkin and Connective Tissue DiseasesSkin Diseases

Intervention Hierarchy (Ancestors)

OxygenGasesInorganic ChemicalsMethylprednisolonePrednisolonePregnadienetriolsPregnadienesPregnanesSteroidsFused-Ring CompoundsPolycyclic Compounds

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor of Anesthesia, ICU, and pain

Study Record Dates

First Submitted

November 10, 2018

First Posted

November 15, 2018

Study Start

November 10, 2018

Primary Completion

July 30, 2019

Study Completion

September 30, 2019

Last Updated

August 5, 2020

Record last verified: 2020-08

Data Sharing

IPD Sharing
Will not share

Locations